United States Minimally Invasive Surgery Device

US Minimally Invasive Surgery Device Market Analysis

The United States Minimally Invasive Surgery Device Market is expected to register a CAGR of 6.4% during the forecast period.

• The COVID-19 pandemic has had an impact on the US minimally invasive surgery device market initially. The market experienced a moderate decline in growth during the pandemic. It was primarily due to the temporary cancellation of treatment and elective procedures and patient visits to the hospitals for the management of chronic diseases other than COVID-19. The pandemic shifted most of the focus of healthcare and research on COVID-19-related diagnosis and patient care, adversely impacting the country's other medical care areas. For instance, in a study published in the Spine Journal by a researcher at NYU Langone Health, the United States, in December 2021, over one-third of elective spinal surgeries got canceled due to the pandemic. However, in the post-pandemic period, the lifting of the lockdown and gradual resumption of the treatment and patient care for the non-COVID medical areas are expected to restore the normal growth rate of the market. For instance, in a study published in the Annals of Medicine and Surgery by the researchers of the University of California San Diego and Rady Children's Hospital, San Diego, in September 2022, the same-day surgery cancellation decreased after the pandemic. The study hypothesized that the required pre-operative COVID diagnosis enabled healthcare providers to reduce the number of surgery cancellations and meet the requirement of the patients. The market is expected to grow further at a stable pace with the increasing demand for minimally invasive surgical devices in the United States.
• The market is expected to grow with a higher acceptance rate of minimally invasive surgeries over traditional surgeries, increasing prevalence of lifestyle-related and chronic disorders, and technological advancements. The prevalence of chronic diseases is on the rise in the United States, which is expected to create more demand for minimally invasive surgical devices for the management of diseases. For instance, according to data published by the CRT Group Foundation in August 2022, the number of individuals living with hypertension will increase by 27.2% to 162.5 million from 127.8 million during the period of 2025 to 2060. As per the data published by the US Census Bureau in November 2022, more than 34 million adults live with diabetes in the United States, and 88 million more individuals are at risk of developing the disease. Several studies have underlined the advantage of minimally invasive surgical devices, which promotes the adoption of these devices for performing surgical interventions.
• A study published in the Frontiers in Robotics and AI by researchers of New York University in January 2022 highlighted the advantages offered by minimally invasive surgical devices, such as shorter hospital stays, decreased postoperative pain, better and faster recovery, and decreased learning curve for the surgical trainees. As per a study published in the JAMA Network by researchers from the United States in September 2022, minimally invasive nephrectomy showcased better efficacy and cost-effectiveness. Thus, with the increasing number of chronic diseases, the advantage of minimally invasive surgeries and devices, and the demand for minimally invasive surgical devices, the market is expected to grow further during the forecast period in the United States.
• Therefore, owing to the aforementioned factors, the market studied is anticipated to witness growth over the analysis period. However, the shortage of experienced professionals and uncertain regulatory frameworks are likely to impede the market's growth.

US Minimally Invasive Surgery Device Market Trends

The Laparoscopic Devices Segment is Expected to Witness Significant Growth Over the Forecast Period

• Minimally invasive laparoscopic devices are utilized for the diagnosis of a wide variety of medical conditions that develop inside the pelvis or abdomen. Laparoscopic devices are used to perform a surgical procedure or retrieve tissue for testing (biopsies). The segment is expected to grow further with its vast usage for various medical conditions and its technological advancements.
• A study published in the journal Sensor (Basel) by US researchers in April 2022 highlighted a fully insertable robotic imaging device and stated the high potential of such minimally invasive devices for surgical interventions. The study demonstrated a tetherless insertable surgical camera (s-CAM) robot combined with a non-contact transabdominal actuation for performing a single-incision laparoscopic surgery.
• A study published in the journal Surgery by researchers from the United States in October 2021 mentioned that minimally invasive laparoscopic surgery had reduced risk of septic shocks or sepsis in patients of ulcerative colitis with preoperative chronic steroid use. The study further emphasized the positive potential of such surgeries for ulcerative colitis patients who undergo total abdominal colectomy.
• Such promising outcomes and benefits of minimally invasive laparoscopic surgery are expected to create more demand for minimally invasive laparoscopic procedures and devices.
• Therefore, the laparoscopic devices segment is expected to witness significant growth over the forecast period due to the abovementioned factors, including its vast application for the diagnosis and procedure of various medical conditions.

The Gastrointestinal Segment is Expected to Witness Significant Growth Over the Forecast Period

• The gastrointestinal segment is expected to grow further with the rising incidence of gastrointestinal diseases in the United States, which would drive the demand for more minimally invasive gastrointestinal procedures and devices.
• In the United States, the prevalence of various gastrointestinal diseases has been rising. As per the data published by the American Cancer Society in 2023, over 153,020 new cases of colorectum cancer are expected in the United States in 2023.
• Minimally invasive surgery has gained popularity for benign diseases and has proved its safety and efficacy over traditional methods, owing to which it has gained substantial attention in the past several years.
• A study published in the Annals of Surgical Oncology by the researchers of the Memorial Sloan Kettering Cancer Center in the United States in July 2021 demonstrated the long-term survival and operative safety of minimally invasive gastrectomy.
• The gastrointestinal segment is expected to witness significant growth over the forecast period due to factors including the high prevalence of gastrointestinal diseases and the high efficacy and safety offered by minimally invasive procedures for gastrointestinal diseases.

US Minimally Invasive Surgery Device Industry Overview

The US minimally invasive surgery device market is fragmented in nature due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of several international as well as local companies that hold market shares and are well known, including Olympus Corporation, Medtronic PLC, GE Healthcare, Siemens Healthiness, and Smith & Nephew. Abbott Laboratories, Intuitive Surgical Inc., Koninklijke Philips NV, Stryker Corporation, and Zimmer Biomet, among others.

US Minimally Invasive Surgery Device Market Leaders

US Minimally Invasive Surgery Device Market News

• January 2023: GE HealthCare acquired IMACTIS. The acquisition would strengthen the portfolio of GE HealthCare with the diverse product line of IMACTIS CT-Navigation used for performing a wide variety of minimally invasive percutaneous procedures.
• November 2022: New View Surgical Inc., a minimally invasive surgery (MIS) device company, received funding worth USD 12.1 million from its investors in the Series B-1 round. The funding accelerated the commercialization of the company's VisionPort System and its launch in the United States.